Clinical Trial Update: Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

This document reports the completion status of a Phase 2 trial evaluating ATI-2138 in adults with moderate to severe atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ATI-2138

Snippet

Sponsor: Aclaris Therapeutics, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED